Properties
What is it?
Indications: MONTELUKAST prophylactic and long-term therapy for bronchial asthma (including prevention of daytime and nighttime symptoms); treatment of patients with aspirin-sensitive bronchial asthma; prophylaxis of exercise-induced bronchoconstriction; treatment of symptoms of seasonal and perennial allergic rhinitis. Dosage and Administration: For adult patients aged 15 years and older with bronchial asthma and/or allergic rhinitis (seasonal, perennial): the daily dose is one 10 mg film-coated tablet once daily, at bedtime (in the evening). For pediatric patients aged 2-5 years with bronchial asthma and/or allergic rhinitis (seasonal, perennial), the daily dose is one 4 mg chewable tablet once daily, at bedtime (in the evening). For pediatric patients aged 6-14 years with bronchial asthma and/or allergic rhinitis (seasonal, perennial): the daily dose is one 5 mg chewable tablet once daily, at bedtime (in the evening). Contraindications: *The preparation is not used in patients with hypersensitivity to the active substance or any of its components. *Pregnancy and lactation. There is insufficient data on the use of montelukast during pregnancy. Therefore, VANSÉAR should not be used during pregnancy except in cases of absolute necessity. It is not known whether VANSÉAR penetrates into breast milk, as many drugs are excreted in human milk, VANSÉAR should be given to a nursing mother with great caution. Storage Conditions: The preparation should be stored at a temperature not exceeding 25C, out of reach of children. Shelf Life: 2 years. Dispensing Conditions: The preparation is dispensed by prescription only.